 |
 |

Therapeutic Ionizing Radiation and the Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma
Michael D. Lichter, MD;
Margaret R. Karagas, PhD;
Leila A. Mott, MS;
Steven K. Spencer, MD;
Thérèse A. Stukel, PhD;
E. Robert Greenberg, MD;
for the New Hampshire Skin Cancer Study Group
Arch Dermatol. 2000;136:1007-1011.
Objective To estimate the relative risk of developing basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) after receiving therapeutic ionizing radiation.
Design Population-based case-control study.
Setting New Hampshire.
Patients A total of 592 cases of BCC and 289 cases of SCC identified through a statewide surveillance system and 536 age- and sex-matched controls selected from population lists.
Main Outcome Measures Histologically confirmed BCC and invasive SCC diagnosed between July 1, 1993, through June 30, 1995, among New Hampshire residents.
Results Information regarding radiotherapy and other factors was obtained through personal interviews. An attempt was made to review the radiation treatment records of subjects who reported a history of radiotherapy. Overall, an increased risk of both BCC and SCC was found in relation to therapeutic ionizing radiation. Elevated risks were confined to the site of radiation exposure (BCC odds ratio, 3.30; 95% confidence interval, 1.60-6.81; SCC odds ratio, 2.94; 95% confidence interval, 1.30-6.67) and were most pronounced for those irradiated for acne exposure. For SCC, an association with radiotherapy was observed only among those whose skin was likely to sunburn with sun exposure.
Conclusions These results largely agree with those of previous studies on the risk of BCC in relation to ionizing radiation exposure. In addition, they suggest that the risk of SCC may be increased by radiotherapy, especially in individuals prone to sunburn with sun exposure.
From Nashua Dermatology Associates, Nashua, NH (Dr Lichter), and the Section of Biostatistics and Epidemiology, Department of Community and Family Medicine, and the Norris Cotton Cancer Center (Drs Karagas, Stukel, and Greenberg, and Ms Mott), Section of Dermatology (Dr Spencer), Department of Medicine, Dartmouth Medical School, Lebanon, NH. The authors have no commercial, proprietary, or financial interests in the products or companies described in this article.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2000;136(8):1072-1073.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer
Parrella et al.
J. Clin. Pathol. 2006;59:1181-1185.
ABSTRACT
| FULL TEXT
Nonmelanoma Skin and Mucosal Cancers After Hematopoietic Cell Transplantation
Leisenring et al.
JCO 2006;24:1119-1126.
ABSTRACT
| FULL TEXT
Basal-Cell Carcinoma.
Rubin et al.
NEJM 2005;353:2262-2269.
FULL TEXT
The role of damage to the cutaneous system in radiation-induced multi-organ failure
Meineke
Br. J. Radiol. 2005;Supplement_27:95-99.
ABSTRACT
| FULL TEXT
The XRCC1 Arg399Gln Polymorphism, Sunburn, and Non-melanoma Skin Cancer: Evidence of Gene-Environment Interaction
Nelson et al.
Cancer Res. 2002;62:152-155.
ABSTRACT
| FULL TEXT
|